Platelets (PLT) > ,/mm^
Platelets (Plt) >= , x ^/L
Platelets (PLT) >= ,/mcL
Platelets (PLT) >= , obtained =<  days prior to registration
Platelets (PLT) ? 
Platelets (plt) >=  x ^/L
Platelets (Plt) >= ,/mm^
Platelets (PLT) ? , cells/mm
Platelets (plt) >=  x ^/L, within  days start of study start
Platelets (PLT) < , K/mcL
Platelets (plt) >=  K/cu mm; for subjects with plt <  K/cu mm due to significant marrow involvement by MCL, plt must be >  K/cu mm
Platelets (PLT) >=  x ^/L without transfusions
Within  days prior to study entry: Platelets (Plt) >=  x ^/L
Platelets (Plt) >= ,
Platelets (PLT) >= ,
Platelets (PLT) >=  x ^/L without transfusions
Platelets (PLT) >= , cells/mm^ for  days after recovery from ASCT nadir
Platelets (plt) ?  x /L,
Platelets (PLT) >= ,
Platelets (PLT) >= ,/mcL
Platelets (plt) ?  x /L.
Platelets (Plt) ? x /L.
Within  days of study start: Platelets (plt) >=  x ^/L
Platelets (PLT) < x /L (x/L)
Platelets (PLT) >= ,/mm^
Platelets (Plt) > 
Platelets (plt) >=  x ^/L
Platelets (PLT) >= , mL
Platelets (plt) >=  x ^/L
Platelets (plt) >=  x ^/L
Obtained =<  days prior to registration: Platelets (PLT) >= ,/mm^
Platelets (Plt) >= ,/mcL
Platelets (PLT) =< K
Platelets (PLT) > ,/ml
Platelets (PLT) >=  x ^/L without transfusions
Platelets (PLT) >= ,
Platelets (plt) >=  x ^/L
Platelets (PLT) >= ,/mcL
Platelets (PLT) >=  x ^/L without transfusions
Platelets (PLT) >= ,/?L obtained =<  days prior to registration
Plt >  K/ml (without transfusion)
Platelets (PLT) >= ,/mm^
Platelets (PLT) >= ,/mm^
Platelets (PLT) >=  x ^/L without transfusions
Subject has a hematologic malignancy with hypoproliferative thrombocytopenia and is expected to have PLT count(s) ? ,/L requiring ?  PLT transfusions
Currently taking, or participating in a clinical study involving PLT substitutes, PLT growth factors, or pharmacologic agents intended to enhance (ie, antifibrinolytic agents) or decrease PLT hemostatic function
Coagulopathy with platelets (Plt) <  k
